Office of Social Security Center: 0943-322 1898 Huining County Medical Security Bureau is a new department established by institutional reform in Huining County. It is the working department of the People's Government of Huining County, located on the seventh floor of Jiahe Building, Modern Road, Huishi Town, Huining County.

：

People's Republic of China (PRC) National Health Insurance Bureau is an institution directly under the State Council, with a deputy ministerial level, which was established on March 20 18. Its main functions are to formulate policies, plans and standards for medical insurance, maternity insurance, medical assistance and other medical security systems and organize their implementation, supervise and manage relevant medical security funds, improve the national platform for medical treatment management and expense settlement in different places, organize the formulation and adjustment of prices and charging standards for drugs and medical services, formulate bidding and purchasing policies for drugs and medical consumables and supervise their implementation, and supervise and manage related service behaviors and medical expenses of medical institutions included in medical insurance.

In order to improve the unified basic medical insurance system and serious illness insurance system for urban and rural residents, continuously improve the level of medical insurance, ensure the rational use, safety and controllability of medical insurance funds, promote the reform of "three-medical linkage" of medical care, medical insurance and medicine as a whole, and better protect the sick people, the State Council proposed an institutional reform plan. Integrate the responsibilities of basic medical insurance and maternity insurance for urban workers and urban residents in Ministry of Human Resources and Social Security, the responsibilities of the National Health and Family Planning Commission for the new rural cooperative medical care, the responsibilities of the National Development and Reform Commission for the price management of drugs and medical services, and the responsibilities of the Ministry of Civil Affairs for medical assistance, and set up the National Medical Security Bureau as a directly affiliated institution of the State Council.

2065438+In March, 2008, the first meeting of the 13th National People's Congress passed the Decision on the Institutional Reform Plan of the State Council, and established the National Health Insurance Bureau of People's Republic of China (PRC). In the past, the health department and the human society department argued endlessly about who was responsible for drug procurement. Now that the country has given the answer, the medical insurance bureau will take over the whole problem.

As early as 2065438+June 28th, 2007, the State Council promulgated "Guiding Opinions on Further Deepening the Reform of Payment Mode of Basic Medical Insurance", which emphasized its importance and urgency and promoted the reform of medical insurance payment mode to a new height.

The Guiding Opinions proposes to improve the medical insurance payment mechanism and interest adjustment mechanism, implement refined management, stimulate the endogenous motivation of medical institutions to standardize behaviors, control costs, rationally treat and refer patients, guide the rational allocation of medical resources and orderly medical treatment for patients, support the establishment of graded diagnosis and treatment mode and the healthy development of primary medical and health institutions, and effectively protect the basic medical rights and interests of the majority of insured personnel and the long-term sustainable development of the medical insurance system. It can be seen that the establishment of the National Health Insurance Bureau will greatly promote the implementation of this document and will have a very important impact on medical institutions and pharmaceutical companies. The medical insurance bureau has become the most concerned department for pharmaceutical companies and medical device companies.

After the establishment of the Medical Security Bureau, it will become the most concerned government department for pharmaceutical companies and medical device enterprises. There are three reasons:

1, market access For the domestic pharmaceutical industry, what exactly is market access can be narrowly understood as: bidding and entering medical insurance. If the drug fails to pass the tender, it means losing the whole hospital market. Furthermore, if the drug fails to enter the medical insurance catalogue, even if it passes the bidding, it will have a very huge impact on its market. Bidding and medical insurance catalogue are both market access, but now these two rights are in the hands of medical insurance bureau, and their importance is self-evident.

2. Strictly controlling drug use and medical insurance expenses are obviously the key words of 20 18. Under the big action of medical insurance fee control, for pharmaceutical companies, entering the catalogue is only a threshold, and hospital access and medical insurance payment standards are the most important. The medical insurance bureau has the right to control the cost from the source, and will have direct control over the drugs and auxiliary drugs that were used in large quantities before. In addition, under the medical insurance payment standard, hospitals will be prompted to use the lowest-cost drugs to treat patients on the basis of rational drug use. No, in the medical insurance environment, the game of interests of all parties will be more obvious.

3. Directly determine the drug price. Before that, the National Development and Reform Commission managed the pricing, the Ministry of Human Resources and Social Security managed the medical insurance catalogue, the Health Planning Commission managed the bidding and purchasing, and finally the medical insurance paid the bill. Those who spend money can't talk about the price, and the management can't regulate the use, which leads to increasing pressure on medical insurance. Nowadays, the Medical Insurance Bureau has taken over the bidding and purchasing of drugs, which embodies the principle of "whoever pays, who trades". On the other hand, under the realistic medical insurance funds, the winning bid price of drugs will be closely tied with the medical insurance payment standard to maximize the interests of all parties. In this case, the hospital or medical association can negotiate the drug price according to the medical insurance payment standard. They can even entrust a third-party platform.